APAM - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

152-11-4

盐酸维拉帕米;
alpha-[3-[[2-(3,4-二甲氧苯基)乙基]甲氨基]丙基]-alpha-异丙基-3,4-二甲氧基苯乙腈盐酸盐

(+/-)-VerAPAMil hydrochloride;
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride;
5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2

依维莫司

Everolimus;
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
40-O-(2-Hydroxyethyl)rAPAMycin;
42-O-(2-Hydroxy)ethylrAPAMycin;
Certican;
Everolimus;
RAD;
RAD 001;
SDZ-RAD;
XIENCE V

APAMin

APAMin;
32,15-(Iminoethaniminopropanodithiomethano)-31H-pyrrolo[2,1-e1][1,2,5,8,11,14,17,20,23,26,29,32,35,38]dithiadodecaazacyclohentetracontine,cyclic peptide deriv.;
66: PN: WO2008088422 FIGURE: 8 claimed protein;
68: PN:WO2006116156 SEQID: 68 claimed protein;
APAMin (reduced), cyclic (1®
11),(3®
15)-bis(disulfide);
APAMine;
L-Histidinamide,L-cysteinyl-L-asparaginyl-L-cysteinyl-L-lysyl-L-alanyl-L-prolyl-L-a-glutamyl-L-threonyl-L-alanyl-L-leucyl-L-cysteinyl-L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-glutaminyl-L-glutaminyl-,cyclic (1®
11),(3®
15)-bis(disulfide);
Ro 23-6721

APAMin (reduced)(8CI,9CI);
L-Histidinamide,L-cysteinyl-L-asparaginyl-L-cysteinyl-L-lysyl-L-alanyl-L-prolyl-L-a-glutamyl-L-threonyl-L-alanyl-L-leucyl-L-cysteinyl-L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-glutaminyl-L-glutaminyl-

无

APAMin,N-[N-(4-azido-2-nitrophenyl)glycyl]-18-[(iodo-125I)-L-histidinamide]- (9CI);
32,15-(Iminoethaniminopropanodithiomethano)-31H-pyrrolo[2,1-e1][1,2,5,8,11,14,17,20,23,26,29,32,35,38]dithiadodecaazacyclohentetracontine,cyclic peptide deriv.

Benzeneacetonitrile, a-dodecyl-3,4,5-trimethoxy-a-[3-[[2-(3-methoxyphenyl)ethyl]methylamino]propyl]-;
DagAPAMil

Benzamide,3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-5-hydroxy-2-methyl-1H-indol-1-yl)-;
5-HydroxyindAPAMide

戈洛帕米;
戈洛帕米;
甲氧戊脉安;
(±)-甲氧基维拉帕米盐酸盐

methoxyverAPAMil hydrochloride;
5-[(3,4-dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile;
5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile;
methoxyverAPAMil;
(+/-)-methoxyverAPAMil hydrochloride (d6 00) (gallopamil);
(±)-α-[3-[(2-(3,4-dimethoxyphenyl)ethyl)methylamino]propyl]-3,4,5-trimethoxy-α-(1-methylethyl)benzeneacetonitrile hydrochloride;
d600, gallopamil, (±)-α-[3-[(2-(3,4-dimethoxyphenyl)ethyl)methylamino]propyl]-3,4,5-trimethoxy-α-(1-methylethyl)benzeneacetonitrile hydrochloride;
α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-α-isopropylbenzeneacetonitrile;
α-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylamino]propyl]-3,4,5-trimethoxy-α-isopropylbenzeneacetonitrile

RAPAMycin,42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-;
42-(1-Tetrazolyl)rAPAMycin;
A 179578;
ABT 578;
Zotarolimus

RAPAMycin,32-O-demethyl- (9CI);
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
23,27-Epoxy-5H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone,3,4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-octadecahydro-9,10,27-trihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-21-methoxy-6,8,12,14,20,26-hexamethyl-,(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-;
32-DesmethylrAPAMycin;
32-O-DemethylrAPAMycin;
CJ 12265;
N 929-89Cb

RAPAMycin,41-O-demethyl-;
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
41-O-Demethyl rAPAMycin;
CJ 12434;
N 469-34A

RAPAMycin, 15-deoxo-;
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
15-DeoxorAPAMycin;
CJ 12573

RAPAMycin,7-O-demethyl-;
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
CJ 12263;
N 929-89B

RAPAMycin,7,32-di-O-demethyl- (9CI);
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rAPAMycin deriv.;
7,29-DesmethylrAPAMycin;
CJ 12225;
N 929-89A

R-维拉帕米

R(+)-VERAPAMIL HYDROCHLORIDE;
R(+)-VERAPAMIL HYDROCHLORIDE;
(+)-VERAPAMIL, METHOXY-, HYDROCHLORIDE;
(+)-METHOXYVERAPAMIL HYDROCHLORIDE

(S)-VerAPAMilamide;
(S)- -Cyano-N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-N-methyl--(1-methylethyl)benzenebutanamide;
(S)-VerAPAMilamide

(S)-(-)-VerAPAMilic Acid;
(S)-(-)-VerAPAMilic Acid;
(S)-4-Cyano-4-(3,4-dimethoxyphenyl)-5-methylhexanoic Acid;
(S)--Cyano-3,4-dimethoxy--(1-methylethyl)-benzenebutanoic Acid;
l--Cyano--(3,4-dimethoxyphenyl)--isopropylbutyric Acid

(R)-VerAPAMilic Acid (S)-α-Methylbenzylamine Salt;
(aS)-α-Methyl-benzenemethanamine (R)--Cyano-3,4-dimethoxy --(1-methylethyl)benzenebutanoate;
(R)-VerAPAMilic Acid (S)-α-Methylbenzylamine Salt;
(aS)-a-Methyl-benzenemethanamine (R)--Cyano-3,4-dimethoxy --(1-methylethyl)benzenebutanoate;
(R)-VerAPAMilic Acid (S)-a-Methylbenzylamine Salt

(S)-(-)-NorverAPAMil Hydrochloride;
(aS)-a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile Hydrochloride;
(S)-(-)-NorverAPAMil Hydrochloride;
(S)-NorverAPAMil Hydrochlorid;
Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, (aS)-;
S-NorverAPAMil;
(aS)-α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-benzeneacetonitrile Hydrochloride

盐酸去甲维拉帕米

NORVERAPAMIL HYDROCHLORIDE;
NORVERAPAMIL HCL;
NORVERAPAMIL HYDROCHLORIDE;
(+/-)-VERAPAMIL, NOR-METHYL-, HYDROCHLORIDE;
(+-)-VERAPAMIL HYDROCHLORIDE, NOR-METHYL (NORVERAPAMIL HYDROCH;
a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitril;
n-nor-(±)-verAPAMil hydrochloride;
α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-α-(1-methylethyl)- benzeneacetonitrile;
a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile

C26H36N2O4

详情

供应商

化工产品